Traditional Chinese medicine composition for preventing restenosis after percutaneous coronary intervention
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A coronary artery and restenosis technology, applied in the field of traditional Chinese medicine, can solve the problems of drug stenosis and other problems, achieve the effect of reducing restenosis, improving the quality of life, and good patient compliance
Inactive Publication Date: 2016-05-18
刘元梅
View PDF1 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Although people continue to apply new drugs and new technology methods to clinical practice, there is still no ideal drug to prevent restenosis.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0037] A traditional Chinese medicine composition for preventing restenosis after coronary artery stent operation, which is composed of 9 grams of sumac, 6 grams of valerian, 4 grams of Chinese rose, 15 grams of pangolin, 4 grams of pomelo flower, 15 grams of sage vine, and 30 grams of motherwort , 20 grams of Forsythia, 12 grams of Geshanxiao, and 10 grams of Tujianqi are made into water decoction according to conventional Chinese medicine preparation technology, one dose per person per day.
Embodiment 2
[0039] A traditional Chinese medicine composition for preventing restenosis after coronary artery stent operation, which is composed of 6 grams of sumac, 5 grams of valerian, 3 grams of rose flower, 12 grams of pangolin, 3 grams of pomelo flower, 12 grams of sage vine, and 20 grams of motherwort , 15 grams of Forsythia, 10 grams of Geshanxiao, and 8 parts of Tujianqi are made into water decoction according to conventional Chinese medicine preparation technology, one dose per person per day.
Embodiment 3
[0041] A traditional Chinese medicine composition for preventing restenosis after coronary artery stent operation, which is composed of 3 grams of sumac, 4 grams of valerian, 2 grams of Chinese rose, 9 grams of pangolin, 2 grams of pomelo flower, 9 grams of Rhododendron, and 10 grams of Motherwort , Forsythia 10 grams, Geshanxiao 8 grams, and Tujianqi 6 grams are made into water decoction according to conventional Chinese medicine preparation technology, one dose per person per day.
[0042] The traditional Chinese medicine composition in the embodiment 1~3 can also be prepared into honeyed pills, concentrated water honeyed pills, watered pills, granules, capsules, tablets, powders, ointment, oral liquid. Its effect is the same as that of water decoction.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a traditional Chinese medicine composition for preventing restenosis after percutaneous coronary intervention. The traditional Chinese medicine preparation is prepared from the following raw medicines: sapanwood, valerian, Chinese rose, dioscorea nipponica, pummelo flower, sargentg loryvine, motherwort, forsythia, auriculate swallowwort root and longflower stringbush root. The traditional Chinese medicine composition for preventing restenosis after percutaneous coronary intervention, provided by the invention, is capable of reducing the death rate, relieving symptoms, reducing restenosis occurrence, improving the life quality of patients, reducing the treatment cost and ensuring that the patient dependence is good. By adopting a water decoction of the traditional Chinese medicine composition for preventing restenosis after percutaneous coronary intervention, provided by the invention, for treating 40 patients for six months, the restenosis rate of a treatment group is 12.50%, and the restenosis rate of a control group is 32.50%, so that the restenosis rate of the treatment group is obviously lower than the restenosis rate of the control group, wherein P is less than 0.05.
Description
technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for preventing restenosis after coronary artery stenting. Background technique [0002] Coronary artery stent implantation has become the main means of interventional treatment of coronary heart disease. The application of intracoronary stents reduces the rate of restenosis after coronary intervention to less than 30%, but the treatment of restenosis in stents is still a difficult problem. Although people continue to apply new drugs and new technologies to clinical practice, there is still no ideal drug to prevent restenosis. Seeking traditional Chinese medicine to prevent restenosis after coronary artery stenting has become a research hotspot. The present inventor draws on the mature experience of treating coronary heart disease with traditional Chinese medicine, analyzes the pathogenesis of traditional Chinese me...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more